E. Murakami

Influence of fatty liver on plasma small, dense LDL- cholesterol in subjects with and without metabolic syndrome.

Ikumi Sugino, K. Kuboki, Tomoko Matsumoto, 2011, Journal of atherosclerosis and thrombosis.

Rosuvastatin Reduces Plasma Small Dense LDL-Cholesterol Predominantly in Non-Diabetic Hypercholesterolemic Patients

K. Kuboki, Tomoko Matsumoto, E. Murakami, 2012 .

Urinary Myoinositol Index: A New and Better Marker for Postmeal Hyperglycemia

K. Kuboki, Tomoko Matsumoto, E. Murakami, 2012 .

Thrombin in synovial fluid as a marker of synovial inflammation: a definite measurement by ELISA and correlation with VEGF.

E. Murakami, T. Imamura, H. Tokunaga, 2008, Clinica chimica acta; international journal of clinical chemistry.

Effect of rosuvastatin on concentrations of plasma lipids, urine and plasma oxidative stress markers, and plasma high-sensitivity C-reactive protein in hypercholesterolemic patients with and without type 2 diabetes mellitus: A 12-week, open-label, pilot study.

Tomoko Matsumoto, E. Murakami, G. Yoshino, 2009, Current therapeutic research, clinical and experimental.

Effects of valsartan on inflammatory and oxidative stress markers in hypertensive, hyperglycemic patients: an open-label, prospective study.

K. Kuboki, E. Murakami, G. Yoshino, 2007, Current therapeutic research, clinical and experimental.